This handout is for acute opioid overdose. Your care team identified this based on: respiratory depression + miosis + altered mental status — aha 2020 opioid-associated emergency triad.
Other reasons your team may use this plan: witnessed opioid ingestion or injection with obtundation — samhsa 2024; found unresponsive with opioid paraphernalia or known opioid use — aha 2020; ems naloxone administered prehospital with partial or full response — samhsa 2024.
Take these medications exactly as prescribed. Do not stop or change a dose without talking to your provider.
| Medication | Starting dose | How | When | What it does |
|---|---|---|---|---|
| naloxone | 0.04 mg IV | IV | q2-3min titrate to RR >12 | Start low (0.04 mg) to restore ventilation without precipitating severe withdrawal; titrate to respiratory rate NOT consciousness — AHA 2020 ACLS opioid algorithm |
Plan: Naloxone dosing ladder for opioid-induced respiratory depression — AHA 2020; FDA 2023
Use these zones to know what to do based on how you feel.
Call 911 or go to the nearest emergency room right away if you have:
Naloxone rescue kit prescription (FDA 2023 OTC); MOUD referral or buprenorphine ED-initiation (SAMHSA 2024); harm reduction counselling; overdose education for patient and family — SAMHSA 2024
Guideline: AHA 2020 Part 3 Adult BLS/ALS — opioid-associated emergency algorithm (Circulation) + AHA 2021 opioid-associated out-of-hospital cardiac arrest scientific statement + van Lemmen et al, Anesthesiology 2023 opioid overdose / naloxone review + SAMHSA 2024 overdose prevention toolkit + FDA 2023 OTC naloxone